You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 370 Tumor-wide neoantigen-specific T-cells infiltrating mutant IDH1 low-grade gliomas and persisting in peripheral blood allow for personalized TCR-based immunotherapies

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
370 Tumor-wide neoantigen-specific T-cells infiltrating mutant IDH1 low-grade gliomas and persisting in peripheral blood allow for personalized TCR-based immunotherapies

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202314009
Dec 20234906
Jan 20241601
Feb 20241801
Mar 20241401
Apr 20242202
May 2024600
Jun 20241000
Jul 20242803
Aug 20241402
Sep 20241800
Oct 20242005
Nov 20242604
Dec 20241405
Jan 20251605
Feb 2025005
Mar 2025009
Apr 2025001
May 2025003
Jun 2025002
Total411064